Abstract
We report an optimized set of CGenFF parameters that can be used to model small molecules containing acylphosphate and N-phosphonosulfonimidoyl functional groups in combination with the CHARMM force field. Standard CGenFF procedures were followed to obtain bonded interaction parameters, which were validated by geometry optimizations, comparison to the results of calculations at the MP2/6-31+G(d) level of theory, and molecular dynamics simulations. In addition, partial atomic charges were assigned so that the energy of hydrogen bonding of the model compounds with water was correctly reproduced. The availability of these parameters will facilitate computational studies of enzymes that generate acyladenylate intermediates during catalytic turnover. In addition, given that the N-phosphonosulfonimidoyl moiety is a stable transition state analog for the reaction of ammonia with an acyladenylate, the parameters developed in this study should find use in efforts to develop novel and potent inhibitors of various glutamine-dependent amidotransferases that have been validated as drug targets. Topology and parameter files for the model compounds used in this study, which can be combined with other CGenFF parameters in computational studies of more complicated acylphosphates and N-phosphonosulfonimidates are made available.
Similar content being viewed by others
References
Frey PA, Hegeman AD (2007) Enzymatic reaction mechanisms. Oxford University Press, Oxford
Agarwal V, Nair SK (2012) Aminoacyl tRNA synthetases as targets for antibacterial development. Med Chem Commun 3:887–898
LaRonde-LeBlanc N, Resto M, Gerratana B (2009) Regulation of active site coupling in glutamine-dependent NAD+ synthetase. Nat Struct Mol Biol 16:421–429
Duckworth BP, Nelson KM, Aldrich CC (2012) Adenylating enzymes as drug targets in Mycobacterium tuberculosis. Curr Top Med Chem 12:766–796
Curnow AW, Hong KW, Yuan R, Kim SI, Martins O, Winkler W, Henkin TM, Soll D (1997) Glu-tRNA(Gln) amidotransferase: a novel heterotrimeric enzyme required for correct decoding of glutamine codons during translation. Proc Natl Acad Sci U S A 94:11819–11826
Horiuchi KY, Harpel MR, Shen L, Luo Y, Rogers KC, Copeland RA (2001) Mechanistic studies of reaction coupling in Glu-tRNA(Gln) amidotransferase. Biochemistry 40:6450–6457
Oshikane H, Sheppard K, Fukai S, Nakamura Y, Ishitani R, Numata T, Sherrer RI, Feng L, Schmitt E, Panvert M, Blanquet S, Mchulam Y, Soll D, Nureki O (2006) Structural recruitment of glutamine to the genetic code. Science 312:1950–1954
Richards NGJ, Kilberg MS (2006) Asparagine synthetase chemotherapy. Annu Rev Biochem 75:629–654
Sircar K, Huang H, Hu LM, Cogdell D, Dhillon J, Tzelepi V, Efstathiou E, Koumakpayi IH, Saad F, Luo DJ, Bismar TA, Aparicio A, Troncoso P, Navone N, Zhang W (2012) Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer. Am J Pathol 180:893–903
Lorenzi PL, Llamas J, Gunsior M, Ozbun L, Reinhold WC, Varma S, Ji H, Kim H, Hutchinson AA, Kohn EC, Goldsmith PK, Birrer MJ, Weinstein JN (2008) Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines. Mol Cancer Ther 7:3123–3128
Aslanian AM, Kilberg MS (2001) Asparagine synthetase expression is sufficient to induce L-asparaginase resistance in MOLT-4 leukemia cells. Biochem J 357:321–328
Tong WH, Pieters R, Hop WCJ, Lanvers-Kaminsky C, Boos J, van der Sluis IM (2013) No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy. Pediatr Blood Cancer 60:258–261
Ikeuchi H, Ahn Y-M, Otokawa T, Watanabe B, Hegazy L, Hiratake J, Richards NGJ (2012) A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells. Bioorg Med Chem 20(5):915–5927
Gutierrez JA, Pan Y-X, Koroniak L, Hiratake J, Kilberg MS, Richards NGJ (2006) An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line. Chem Biol 13:1339–1347
Hann MM, Keserü GM (2012) Finding the sweet spot: the role of nature and nuture in medicinal chemistry. Nat Rev Drug Discov 11:355–365
Walters WP, Green J, Weiss JR, Murcko MA (2011) What do medicinal chemists actually make? A 50-year retrospective. J Med Chem 54:6405–6416
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791
Vanommeslaeghe K, Hatcher E, Acharya C, Kundu S, Zhong S, Shim J, Darian E, Guvench O, Lopes P, Vorobyov I, MacKerell AD Jr (2010) CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem 31:671–690
MacKerell AD, Bashford D, Bellott M et al (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586–3616
Foloppe N, MacKerell AD (2000) All-atom empirical force field for nucleic acids: I Parameter optimization based on small molecule and condensed phase macromolecular target data. J Comput Chem 21:86–104
Vanommeslaeghe K, MacKerell AD Jr (2012) Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing. J Chem Inf Mol Model 52:3144–3154
Vanommeslaeghe K, MacKerell AD Jr (2012) Assignment of bonded parameters and partial atomic charges. J Chem Inf Mol Model 52:3155–3168
Francl MM, Pietro WJ, Hehre WJ, Binkley JS, Gordon MS, DeFrees DJ, Pople JA (1982) Self-consistent molecular orbital methods. XXIII. A polarization-type basis set for second row elements. J Chem Phys 77:3654–3665
Head-Gordon M, Pople JA, Frisch MJ (1988) MP2 energy evaluation by direct methods. Chem Phys Lett 153:503–506
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian 09. Gaussian Inc., Wallingford
Scott AP, Radom L (1996) Harmonic vibrational frequencies: an evaluation of Hartree-Fock, Möller-Plesset, quadratic configuration interaction, density functional theory, and semi-empirical scale factors. J Phys Chem 100:16502–16513
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935
Ditchfield R, Hehre WJ, Pople JA (1971) Self-consistent molecular orbital methods. 9. Extended Gaussian-type basis for molecular orbital studies of organic molecules. J Chem Phys 54:724–728
Frisch MJ, Pople JA, Binkley JS (1984) Self-consistent molecular orbital methods. 25. Supplementary functions for Gaussian basis sets. J Chem Phys 80:3265–3269
Brooks BR, Brooks CL III, MacKerell AD Jr, Nilsson L, Petella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus J (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30:1545–1614
Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an Nlog(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092
Ryckaert JP, Ciccotti G, Berendsen HJC (1977) Numerical integration of Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23:327–341
Tobias DJ, Martyna GJ, Klein ML (1993) Molecular dynamics simulations of a protein in the canonical ensemble. J Phys Chem 97:12959–12966
Feller SE, Zhang Y, Pastor RW, Brooks BR (1995) Constant pressure molecular dynamics simulation. The Langevin piston method. J Chem Phys 103:4613–4621
Hibi T, Nii H, Nakatsu T, Kimura A, Kato H, Hiratake J, Oda J (2004) Crystal structure of γ-glutamylcysteine synthetase: insights into the mechanism of catalysis by a key enzyme for glutathione homeostasis. Proc Natl Acad Sci U S A 101:15052–15057
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera – a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612
Marti-Renom MA, Stuart A, Fiser A, Sánchez R, Melo F, Sali A (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29:291–325
Allen FH (2002) The Cambridge Structural Database: a quarter of a million structures and rising. Acta Crystallogr B 58:380–388
Kirkpatrick S, Gelatt CD Jr, Vecchi MP (1983) Optimization by simulated annealing. Science 220:671–680
Schneider G (2010) Virtual screening: an endless staircase? Nat Rev Drug Discov 9:273–276
Gallicchio E, Levy RM (2011) Recent theoretical and computational advances for modeling protein-ligand binding affinities. Adv Prot Chem Struct Biol 85:27–80
Wang JM, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157–1174
Christen M, Hunenberger PH, Bakowies D, Baron R, Burgi R, Geerke DP, Heinz TN, Kastenholz MA, Krautler V, Oostenbrink C, Peter C, Trzesniak D, van Gunsteren WF (2005) The GROMOS software for biomolecular simulation: GROMOS05. J Comput Chem 26:1719–1751
Nilsson MT, Krajewski WW, Yellagunda S, Prabhumurthy S, Chamarahally GN, Siddamadappa C, Srinivasa BR, Yahiaoui S, Larhed M, Karleén A, Jones TA, Mowbray SL (2009) Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors. J Mol Biol 393:504–513
Lu D, Vince R (2007) Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality. Bioorg Med Chem Lett 17:5614–5619
Hiratake J, Irie T, Tokutake N, Oda J (2002) Recognition of a cysteine substrate by E. coli γ-glutamylcysteine synthetase probed by sulfoximine-based transition-state analogue inhibitors. Biosci Biotechnol Biochem 66:1500–1514
Fyfe PK, Oza SL, Fairlamb AH, Hunter WN (2008) Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities. J Biol Chem 283:17672–17680
Acknowledgments
The authors wish to thank Alex D. MacKerell, Jr., and Kenno Vanommeslaeghe (Maryland) for helpful discussions. Computational resources for this work were provided by the University of Florida High Performance Computing Center. Funding for this work was obtained from the National Institutes of Health (DK061666) and Indiana University Purdue University Indianapolis.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
The calculated QM and MM vibrational spectra together with simulation trajectory data for the N-phosphonosulfonimidoyl derivative 5, and full topology and parameter information for the model compounds (4 and 5) employed in this study, is provided as Supplementary material. (PDF 413 kb)
Rights and permissions
About this article
Cite this article
Hegazy, L., Richards, N.G.J. Optimized CGenFF force-field parameters for acylphosphate and N-phosphonosulfonimidoyl functional groups. J Mol Model 19, 5075–5087 (2013). https://doi.org/10.1007/s00894-013-1990-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-013-1990-x